EMA Gets Specific On Pharmacovigilance Of Drugs Used In Pregnancy
Draft Guideline Issued After Three Year Delay
Executive Summary
A new EU guideline offers recommendations for facilitating appropriate pharmacovigilance for drugs that may be used in pregnant or breastfeeding women.